Fig. 2From: Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral bloodCirculating MDSC cells before and after CRT. PBMCs from 20 patients treated with CRT for lung or head and neck cancer were taken before CRT and 1 month after. HLA-DRlow Lineage− CD33+CD14+CD11b+ MDSC were analyzed by flow cytometry. A and D Representative plots for MDSC (A) in two patients. B MDSC rates variation after CRT, lines in red representing significant increase (> 20%) from baseline (n = 20). C MDSC rates before and after CRT (n = 20). Results are shown as mean (standard deviation). ns, not significant (Wilcoxon test)Back to article page